13.2K subscribers
3 photos
1 video
53.3K links
🔮Science Updates Daily!
🔮Every post with Source Link!
🔮This is 24/7 Working Channel!
🔮Each post is shared from Renowned Websites!

Buy ads: https://telega.io/c/Science_News_Facts_Updates_daily

admin : @The_Lawliet
Download Telegram
Microdosing Psilocybin: No Benefit in Cognitive, Affective, or Social Function in Healthy Individuals 🍄 🧠 😊 🤝

Read Full Article

#Microdosing #Psilocybin #Cognition #Mood #SocialFunction
💯2🤨2🤮1💔1
Long-term antidepressant effects of psilocybin linked to functional brain changes - a single dose of psilocybin altered the electrical properties of brain cells in rats for months, even after physical changes to the neurons had disappeared.

Read Full Article

#psilocybin #antidepressant #neuroscience #brainplasticity #rats
❤4🔥1
In clinical trials of psilocybin for anorexia, many patients do not respond to treatment. New research from Monash University found that in female mice, psilocybin produced different effects on social behavior and inflammation depending on metabolic state and exercise, with no consistent benefit.

Read Full Article

#psilocybin #anorexia #monashuniversity #preclinicalresearch #inflammation
❤2
Science News
In clinical trials of psilocybin for anorexia, many patients do not respond to treatment. New research from Monash University found that in female mice, psilocybin produced different effects on social behavior and inflammation depending on metabolic state…
🍄 Context Matters: Psilocybin Therapy for Anorexia
New research from Monash University suggests that metabolic state and exercise levels in female mice significantly altered psilocybin's effects on social behavior and inflammation, showing no consistent benefit in an anorexia model.

🔬 Mixed Results in Anorexia Trials
Clinical trials for psilocybin in anorexia nervosa are ongoing, but many patients do not respond consistently. A Phase 1 trial noted only 40% of participants showed significant symptom reduction, highlighting the need to understand factors influencing treatment response.

📊 Animal Study Reveals Nuances
In female mice, psilocybin did not uniformly increase social behavior. Its impact varied based on food restriction and exercise, influencing social novelty seeking and motivation differently across groups. IL-6 levels, an inflammation marker, rose only in exercising mice post-psilocybin.

💡 Implications for Psychedelic Treatments
These findings indicate psilocybin is unlikely to be a universal treatment for anorexia nervosa. Factors like exercise, metabolic status, and immune state may be crucial in shaping patient responses to psychedelic therapies.

#Psilocybin #AnorexiaNervosa #MentalHealth
Science News
Low-dose psilocybin reduces weight gain and hyperglycemia in mice fed obesogenic diet. Results showed that, compared to the control group, mice that received psilocybin had reduced body-weight gain, liver steatosis, hyperglycemia, and insulin resistance. …
🍄 Study on mice fed a high-fat/high-fructose diet shows 12 weeks of low-dose psilocybin treatment reduced weight gain, fatty liver, hyperglycemia, and insulin resistance, with no observed central nervous system effects.

🔬 Published in Pharmacological Research, the study by Martina Colognesi and colleagues investigated potential therapeutic effects of non-psychedelic psilocybin doses on obesity, type 2 diabetes, and fatty liver.

⚡ Psilocybin treatment normalized lipid pathways and carbohydrate metabolism in the liver, and improved muscle strength and function by potentially restoring leptin sensitivity in mice.

#Psilocybin #Obesity #Diabetes
Science News
"A new study suggests Psilocybin may do more than just cause a temporary trip and could actually rewire the brain". Researchers found that activating key Serotonin receptors can lead to lasting structural changes in neural connections, helping explain its…
🍄 New study in the Journal of Psychopharmacology suggests psilocybin's anti-depressant effects are linked to serotonin receptor activity and increased brain cell flexibility.

🧠 Researchers led by Connor J. Maltby observed that moderate psilocybin doses in mice reduced anxiety-like behavior, while higher doses showed sustained antidepressant-like effects.

🔬 Psilocybin was found to promote a more flexible state in brain cell structures and increase proteins associated with the brain's ability to adapt, specifically in the prefrontal cortex.

#Psilocybin #MentalHealth #Neuroscience
Science News
A single dose of psilocybin can lead to lasting shifts in a person’s life values, such as an increased appreciation for life and greater self-acceptance. These lasting changes appear to be driven by specific acute effects of the drug, particularly feelings…
🍄 A single dose of psilocybin can lead to lasting changes in personal values, like increased appreciation for life and greater self-acceptance, driven by feelings of unity and euphoria.

🧠 Researchers observed these shifts in personal values occurred at both one-week and twelve-week follow-ups, absent in the placebo group.

✨ The study, involving 89 healthy adults, found that while psilocybin didn't alter personality traits or psychiatric symptoms in this group, the intensity of feelings of "oceanic boundlessness" (euphoria, spiritual awakening, oneness) predicted greater positive value changes.

#PsychedelicResearch #MentalHealth #Psilocybin
Science News
Repeated doses of psilocybin show promise for treating obsessive-compulsive disorder. The findings indicate that repeated weekly treatments are safe and tend to significantly reduce the severity of obsessive thoughts and compulsive behaviors. Read Full Article…
🍄 New clinical trial suggests multiple doses of psilocybin, the active compound in "magic mushrooms," may offer significant relief for obsessive-compulsive disorder (OCD). The study, published in the Journal of Psychopharmacology, found that weekly treatments were safe and effectively reduced obsessive thoughts and compulsive behaviors.

🔬 The research involved 15 adults with moderate to severe OCD who had not responded to standard therapies. After an eight-week program involving weekly high doses of psilocybin, approximately 73% of participants showed at least a 35% reduction in symptom severity, with 40% experiencing complete symptom remission.

🧠 Psilocybin works by affecting serotonin receptors in the brain, increasing cognitive flexibility and altering neural networks associated with habitual responding. This is particularly relevant for OCD, which is characterized by rigid thought patterns and repetitive behaviors.

6️⃣ Follow-up six months later indicated that symptom reductions remained substantial for a large portion of participants, suggesting potential for lasting benefit. Researchers are planning larger-scale studies to further investigate psilocybin's efficacy and optimal dosing for OCD.

#Psilocybin #OCD #MentalHealth
Science News
One or two psilocybin doses still lifting depression a year on Read Full Article #PsilocybinTherapy #DepressionTreatment #PsychedelicResearch
🍄 Psilocybin Shows Lasting Impact on Treatment-Resistant Depression
The EPIsoDE trial, a Phase 2b study involving 144 participants, found that one or two doses of psilocybin, combined with psychotherapy, resulted in a clinically meaningful drop in depression scores that remained stable for a year.

📊 Depression Scores Show Sustained Improvement
On the Hamilton Rating Scale for Depression, scores fell by an average of 7.93 points at six months and 7.74 points at twelve months, with little change between the two time points, regardless of the psilocybin dosing strategy.

💊 Restarting Antidepressants Linked to Higher Depression Scores
Participants who resumed antidepressant medication during the follow-up year showed higher depression scores (nearly four points more) compared to those who did not.

#Psilocybin #Depression #MentalHealth
❤1
Science News
Case report: transient return of speech and continence in advanced dementia patient after 5g psilocybin mushrooms Read Full Article #DementiaResearch #PsychedelicsInMedicine #NeurocognitiveTherapy
🍄 A woman with advanced Alzheimer's, who had been largely non-verbal for five years, experienced significant temporary improvements after taking five grams of Enigma-strain mushrooms.

😴 After an initial difficult phase with autonomic system flares and a prolonged sleep-like state, she began speaking in autobiographical sentences 19 hours after the dose.

🚶‍♀️ In the following days and weeks, she regained continence, walked with less support, dressed herself, made eye contact, and engaged in conversations.

💡 Researchers suggest that some functional capacities lost in late-stage dementia might be inaccessible rather than entirely lost, and a strong neuromodulatory event like psilocybin could temporarily bring them back.

#Alzheimers #Psilocybin #Neuroscience
❤3
Science News
Psilocybin, the active ingredient in magic mushrooms, has shown early promise for treating eating disorders. If confirmed in larger trials, the results suggest that psilocybin therapy could kick-start anorexia recovery and provide relief. Read Full Article…
* 🍄 Christina, a 34-year-old Londoner who battled anorexia nervosa for six years, found hope in a clinical trial for psilocybin, the active ingredient in magic mushrooms, as a treatment.

* 🧠 A pilot trial involving 21 women with anorexia nervosa found that psilocybin combined with talk therapy reduced symptoms and increased motivation to change. In one study, four out of 10 patients saw significant drops in eating disorder scores after a single dose.

* 📅 The U.S. Food and Drug Administration could approve psilocybin for depression or eating disorders within five years. Researchers are exploring how this psychedelic therapy can break down mental barriers and promote recovery.

#Psilocybin #AnorexiaRecovery #MentalHealth

(⚠️ Formatting disabled due to Markdown error)
Science News
America's First Legal Psilocybin Program Treated 346 People. Just one month after the dose, 92.2 percent of participants said the experience had been beneficial, while, on average, their mental health symptoms had fallen dramatically. Read Full Article …
🍄 Oregon's first state-regulated psilocybin program shows promising results for mental health. A study tracked 346 clients from November 2024 to June 2026, finding significant improvements in mental health, well-being, and life satisfaction within three months of taking psilocybin.

📈 Within one month post-dose, 92.2% of participants found the experience beneficial, with dramatic reductions in mental health symptoms. For example, moderate-to-severe PTSD symptoms dropped from 48% to 16.8%.

⚠️ While generally positive, the study noted rare but serious adverse reactions. 1.2% of participants (four individuals) required medical attention, experiencing severe anxiety, depression, violence, or self-harm thoughts, particularly those who were new to psychedelics and received higher doses.

#Psilocybin #MentalHealth #Oregon
❤1
Psilocybin Might Make Your Brain Live in the Moment— Psychedelics are often associated with disconnecting from reality, but a recent neuroimaging study found that psilocybin can actually make our brain activity more attuned to the world around us.

Read Full Article

#Psychedelics #Psilocybin #Neuroimaging
❤2
Science News
Psilocybin Might Make Your Brain Live in the Moment— Psychedelics are often associated with disconnecting from reality, but a recent neuroimaging study found that psilocybin can actually make our brain activity more attuned to the world around us. Read Full…
🧠 New research published in Nature reveals psilocybin may not simply induce brain chaos, but rather create a hidden order.

📊 A large study of 62 participants using fMRI and EEG found that while brain network boundaries blurred under psilocybin, neurological reactions to experiences became more distinct.

✨ AI analysis identified clearer neural signals correlating with the intensity of the psilocybin experience, suggesting a more distinct imprint of reality rather than pure unpredictability.

💖 These findings also align with participants' reports of more intense immersion and unity, providing biological insight into the "oneness" often felt during psychedelic trips and highlighting the importance of context in psychedelic therapy.

#PsychedelicResearch #BrainScience #Psilocybin
Magic mushroom compound may prevent chemotherapy pain: « Research in mice finds that psilocybin protects against nerve damage and sensitivity caused by common cancer drugs. »

Read Full Article

#Psilocybin #Chemotherapy #NerveProtection
❤1🍌1
Science News
A single dose of psilocybin eased depression within days, but its edge over placebo faded within a year. The effects appeared as early as the second day after dosing and lasted for more than three months, although by one year the difference between groups…
✨ A 25-mg dose of psilocybin showed rapid antidepressant effects in a Swedish trial, appearing by day 2 and lasting over three months based on self-reports.

⏳ While initial clinician-rated effects lasted for weeks, the difference between psilocybin and placebo faded by one year.

📊 At 42 days, 53% of psilocybin recipients achieved remission compared to 6% in the placebo group.

💊 Psilocybin was generally well-tolerated with temporary side effects, though two participants experienced prolonged severe anxiety. Blinding proved largely ineffective.

#Psilocybin #DepressionTreatment #ClinicalTrial